SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-043387
Filing Date
2020-04-06
Accepted
2020-04-06 07:16:43
Documents
12
Period of Report
2020-04-05
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2015079-1_8k.htm 8-K 29065
2 EXHIBIT 99.1 tm2015079d1_ex99-1.htm EX-99.1 18966
3 EXHIBIT 99.2 tm2015079d1_ex99-2.htm EX-99.2 6084
4 GRAPHIC tm2015079d1_ex99-1img001.jpg GRAPHIC 14794
5 GRAPHIC tm2015079d1_ex99-2img001.jpg GRAPHIC 78401
6 GRAPHIC tm2015079d1_ex99-2img002.jpg GRAPHIC 20417
7 GRAPHIC tm2015079d1_ex99-2img004.jpg GRAPHIC 35186
8 GRAPHIC tm2015079d1_ex99-2img005.jpg GRAPHIC 83211
9 GRAPHIC tm2015079d1_ex99-2img006.jpg GRAPHIC 48519
10 GRAPHIC tm2015079d1_ex99-2img007.jpg GRAPHIC 86266
11 GRAPHIC tm2015079d1_ex99-2img008.jpg GRAPHIC 76900
12 GRAPHIC tm2015079d1_ex99-2img009.jpg GRAPHIC 178618
  Complete submission text file 0001104659-20-043387.txt   911174
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 20775723
SIC: 2834 Pharmaceutical Preparations